Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - AMERICAN GENE ENGINEER CORP | ex32_1.htm |
EX-31.2 - EXHIBIT 31.2 - AMERICAN GENE ENGINEER CORP | ex31_2.htm |
EX-31.1 - EXHIBIT 31.1 - AMERICAN GENE ENGINEER CORP | ex31_1.htm |
EX-21.1 - EXHIBIT 21.1 - AMERICAN GENE ENGINEER CORP | ex21_1.htm |
10-K - AMERICAN GENE ENGINEER CORP | ag2918010k.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of American Gene Engineer Corp. (the “Company”) on Form 10-K for the year ended October 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Han-Chen Lin, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, thatto my knowledge:
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: February 21, 2018
|
By:
|
/s/ Han-Chen Lin
|
|
|
Han-Chen Lin
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |